APA (7th ed.) Citation

AL, F., C, Z., A, P., J, D., T, S., M, S., . . . S, S. (2019). A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor. Cancers, 11(6), . https://doi.org/10.3390/cancers11060848

Chicago Style (17th ed.) Citation

AL, Fallacara, et al. "A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor." Cancers 11, no. 6 (2019). https://doi.org/10.3390/cancers11060848.

MLA (9th ed.) Citation

AL, Fallacara, et al. "A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor." Cancers, vol. 11, no. 6, 2019, https://doi.org/10.3390/cancers11060848.